|
RAD
|
Rite Aid Corporation
|
US
|
NYSE
|
|
REUN
|
Reunion Neuroscience Inc.
|
US
|
NASDAQ
|
|
RNXT
|
RenovoRx, Inc.
|
US
|
NASDAQ
|
|
RVNC
|
Revance Therapeutics, Inc.
|
US
|
NASDAQ
|
|
RVPH
|
Reviva Pharmaceuticals Holdings, Inc.
|
US
|
NASDAQ
|
|
SAGE
|
Sage Therapeutics, Inc.
|
US
|
NASDAQ
|
|
SCPH
|
scPharmaceuticals Inc.
|
US
|
NASDAQ
|
|
SCYX
|
SCYNEXIS, Inc.
|
US
|
NASDAQ
|
|
TCON
|
TRACON Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
TEVA
|
Teva Pharmaceutical Industries
|
US
|
NYSE
|
|
TFFP
|
TFF Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
TNXP
|
Tonix Pharmaceuticals Holding Corp.
|
US
|
NASDAQ
|
|
VRPX
|
Virpax Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
VTRS
|
Viatris Inc.
|
US
|
NASDAQ
|
|
YCBD
|
cbdMD, Inc.
|
US
|
AMEX
|
|
ZNTL
|
Zentalis Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ZYNE
|
Zynerba Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ATH
|
Alterity Therapeutics Limited
|
AU
|
ASX
|
|
ATX
|
Amplia Therapeutics Limited
|
AU
|
ASX
|
|
AVE
|
Avecho Biotechnology Limited
|
AU
|
ASX
|